The Clorox Company (NYSE:CLX) Shares Bought by Cullen Frost Bankers Inc.

Cullen Frost Bankers Inc. boosted its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 4.3% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 43,877 shares of the company's stock after buying an additional 1,811 shares during the quarter. Cullen Frost Bankers Inc.'s holdings in Clorox were worth $7,126,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Catalyst Capital Advisors LLC acquired a new stake in shares of Clorox in the third quarter valued at $54,000. Los Angeles Capital Management LLC raised its position in Clorox by 5.6% in the 3rd quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company's stock valued at $31,266,000 after purchasing an additional 10,149 shares in the last quarter. Advisors Asset Management Inc. raised its position in Clorox by 43.4% in the 3rd quarter. Advisors Asset Management Inc. now owns 29,865 shares of the company's stock valued at $4,865,000 after purchasing an additional 9,037 shares in the last quarter. Natixis Advisors LLC boosted its stake in shares of Clorox by 8.3% in the 3rd quarter. Natixis Advisors LLC now owns 63,476 shares of the company's stock valued at $10,341,000 after buying an additional 4,839 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its position in shares of Clorox by 1.8% during the third quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company's stock worth $117,932,000 after buying an additional 13,038 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company's stock.

Remove Ads

Clorox Stock Performance

NYSE CLX traded down $3.04 during trading on Monday, reaching $147.99. The company's stock had a trading volume of 2,136,366 shares, compared to its average volume of 1,211,328. The business's fifty day moving average price is $155.65 and its 200-day moving average price is $160.47. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The firm has a market cap of $18.23 billion, a price-to-earnings ratio of 40.43, a P/E/G ratio of 2.62 and a beta of 0.45.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings data on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the prior year, the firm posted $2.16 earnings per share. As a group, analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be paid a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.30%. The ex-dividend date of this dividend is Wednesday, April 23rd. Clorox's dividend payout ratio (DPR) is presently 133.33%.

Wall Street Analyst Weigh In

CLX has been the topic of a number of recent analyst reports. DA Davidson dropped their price objective on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 5th. Barclays raised their price target on Clorox from $130.00 to $140.00 and gave the company an "underweight" rating in a research note on Wednesday, February 5th. Evercore ISI lifted their price target on Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Royal Bank of Canada reiterated a "sector perform" rating and issued a $150.00 price objective on shares of Clorox in a report on Thursday, January 30th. Finally, StockNews.com cut Clorox from a "buy" rating to a "hold" rating in a research note on Sunday, January 5th. Three research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $159.62.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.